Gyre Therapeutics (GYRE) Total Debt Growth (3y) (2013 - 2017)
Powered by 
Analysis
Gyre Therapeutics (GYRE) Total Debt Growth (3y) (2013 - 2017) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 0.08% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.52% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 4.76% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -22.30% |
| 10 | Gyre Therapeutics | 691.38 Mn | 633.98 Mn | 26.90 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2017 | 125.59% |
| Jun 30, 2017 | 102.10% |
| Mar 31, 2017 | 139.75% |
| Dec 31, 2016 | 157.53% |
| Sep 30, 2016 | 180.03% |
| Jun 30, 2016 | 168.65% |
| Mar 31, 2016 | 159.22% |
| Dec 31, 2015 | 157.04% |
| Sep 30, 2015 | 151.16% |
| Sep 30, 2014 | -49.85% |
| Jun 30, 2014 | -45.62% |
| Dec 31, 2013 | -28.12% |